Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HDAC1 | Q13547 | 13/20 | 0.38 |
| ▸ | HDAC6 | Q9UBN7 | 12/20 | 0.37 |
| ▸ | HDAC8 | Q9BY41 | 8/20 | 0.37 |
| ▸ | HDAC2 | Q92769 | 2/20 | 0.36 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.36 |
| ▸ | HDAC7 | Q8WUI4 | 1/20 | 0.36 |
| ▸ | HDAC10 | Q969S8 | 1/20 | 0.36 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.36 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.36 |
| ▸ | NPC1 | O15118 | 1/20 | 0.35 |
| ▸ | RAB9A | P51151 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11301463 | 0.74 | HDAC6 (0.42) | HDAC1HDAC6HDAC8HDAC2HDAC3 | |
| SCHEMBL11299528 | 0.70 | HDAC1 (0.40) | HDAC1HDAC6HDAC8HDAC2HDAC3 | |
| SCHEMBL11297379 | 0.69 | HDAC1 (0.42) | HDAC1HDAC6HDAC8HDAC2HDAC3 | |
| SCHEMBL11300527 | 0.64 | HDAC6 (0.42) | HDAC1HDAC6HDAC8HDAC2HDAC3 | |
| SCHEMBL11299454 | 0.63 | HDAC1 (0.44) | HDAC1HDAC6HDAC8HDAC2HDAC3 | |
| SCHEMBL11300775 | 0.63 | HDAC1 (0.50) | HDAC1HDAC6HDAC8HDAC2HDAC3 | |
| SCHEMBL6919015 | 0.63 | HDAC6 (0.62) | HDAC1HDAC6HDAC8HDAC2HDAC3 | |
| SCHEMBL11301466 | 0.62 | HDAC1 (0.44) | HDAC1HDAC6HDAC8HDAC2HDAC3 | |
| SCHEMBL11301119 | 0.62 | MAPT (0.40) | NPC1RAB9A | |
| SCHEMBL27362053 | 0.60 | HDAC6 (0.68) | HDAC1HDAC6HDAC8HDAC2HDAC3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2665706-A1 | NOVEL 4-AMINO-N-HYDROXY-BENZAMIDES AS HDAC INHIBITORS FOR THE TREATMENT OF CANCER | F.HOFFMANN-LA ROCHE AG (CH) | 2013-11-27 | — | — | EP | claimed |
| WO-2012098132-A1 | NOVEL 4-AMINO-N-HYDROXY-BENZAMIDES AS HDAC INHIBITORS FOR THE TREATMENT OF CANCER | F. HOFFMANN-LA ROCHE AG (CH) | 2012-07-26 | — | — | WO | claimed |
| EP-2665706-A1 | NOVEL 4-AMINO-N-HYDROXY-BENZAMIDES AS HDAC INHIBITORS FOR THE TREATMENT OF CANCER | F.HOFFMANN-LA ROCHE AG (CH) | 2013-11-27 | — | — | EP | disclosed |
| WO-2012098132-A1 | NOVEL 4-AMINO-N-HYDROXY-BENZAMIDES AS HDAC INHIBITORS FOR THE TREATMENT OF CANCER | F. HOFFMANN-LA ROCHE AG (CH) | 2012-07-26 | — | — | WO | disclosed |